Cargando…
Tumour necrosis factor-alpha levels as predictor factor on clinical response of anthracycline-based neoadjuvant chemotherapy in locally advance breast cancer patients: experimental research
The prevalence of locally advanced breast cancer is increasing yearly, so biomarkers are needed to assist in its management, one of which is tumour necrosis factor-alpha (TNF-α). OBJECTIVE: Analysing TNF-α levels as a predictor factor on clinical response anthracycline-based neoadjuvant chemotherapy...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129095/ https://www.ncbi.nlm.nih.gov/pubmed/37113871 http://dx.doi.org/10.1097/MS9.0000000000000424 |